NGNE
Neurogene Inc.
NASDAQ · USHealthcareBiotechnology
$36.84-1.27%
Price as of Jul 20, 2026
NGNE earnings
Neurogene Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 10, 2026in NaN days
EPS est $-1.40 · Revenue est —
Track record
Beat EPS in 7 of 10 quarters
Avg surprise +5.2% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 12, 2026 | $-1.30 | $-1.39 | -7.2% | — | — |
| Mar 24, 2026 | $-1.24 | $-1.12 | +9.6% | — | — |
| Nov 13, 2025 | $-1.26 | $-0.99 | +21.4% | — | — |
| May 9, 2025 | $-1.05 | $-1.08 | -2.9% | — | — |
| Mar 24, 2025 | $-1.04 | $-0.99 | +4.8% | — | — |
| Nov 18, 2024 | $-1.22 | $-1.19 | +2.5% | — | — |
| Aug 9, 2024 | $-1.02 | $-1.09 | -6.9% | $925000 | — |
| May 10, 2024 | $-1.03 | $-1.00 | +2.9% | — | — |
| Nov 14, 2023 | $-0.80 | $-0.41 | +48.8% | — | — |
| Aug 10, 2023 | $-0.15 | $-0.04 | +73.3% | — | — |
| Mar 30, 2019 | — | $-0.09 | — | — | — |
| Sep 29, 2018 | — | $-0.64 | — | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-10.